Biochemistry Flashcards
DNA methylation
- identifies template DNA in replication by methylating Adenine and Cytosine
- blocks DNA transcription by methylating CpG islands
Drugs that inhibit pyrimidine base production pathway
- Leflunomide - inhibits dihydroorotate dehydrogenase which produces orotic acid
- Hydroxyurea - inhibits ribonucleotide reductase which converts UDP to dUDP
- 5-FU - inhibits thymidylate synthase which converts dUMP to dTMP
- MTX, TMP, Pyrimethamine - inhibits DHFR which converts DHF to THF which is needed in conversion of dUMP to dTMP
Drugs that inhibit purine base production pathway
- 6-MP - inhibits conversion of PRPP to IMP
- Mycophenolate and Ribavirin - inhibit conversion of IMP to GMP
Lesch-Nyhan syndrome
- missing HGPRT, can’t convert Hypoxanthine to IMP or guanine to GMP
- get buildup of uric acid and excess de novo purine synthesis
- symptoms: “HGPRT”
Hyperuricemia, Gout, Pissed off (self-mutilation, aggression), Retardation, dysTonia - Tx: allopurinol; febuxostat 2nd line
Adenosine deaminase deficiency
- can’t convert Adenosine to Inosine, get buildup of excess ATP/dATP
- gives feedback inhibition to stop ribonucleotide reductase and block DNA synthesis
- major cause of AR SCID (can’t make LCs)
Fluoroquinolones
inhibit Topo II
Transition vs. Transversion DNA mutation
- Transition: same base type purine to purine or pyrimidine to pyrimidine
- Transversion: changes base type purine to pyrimidine or vice versa
Drugs that block DNA replication MOA
attack the triphosphate bond at the 3’ end of the new DNA strand and add on with their modified OH group, which prevents addition of the next nucleotide and causes “chain termination”
DNA and RNA Polymerases in eukaryotes
DNA: 1 DNA polymerase RNA: I --> rRNA II --> mRNA III --> tRNA
DNA and RNA Polymerases in prokaryotes
DNA:
pol I –> same as pol II but also degrades RNA primer, replaces with DNA
pol III –> elongates strand, proofreads
RNA: 1 RNA polymerase
Nonhomologous end joining
- repairs double stranded breaks by bringing together 2 ends of double-stranded DNA fragments
- mutated in ataxia telangiectasia
Modifications to heterogenous nuclear RNA (makes it into mRNA)
- 5’ cap
- 3’ polyadenylation
- splicing out introns
Splicesosome
the complex of hnRNA combined with snRNPs and other proteins; makes Lariat intermediate, then released when the exons are joined
- *Antibodies to splicesosomal snRNPs are called Anti-Smith Abs, highly specific for SLE!!
- *Abs against U1 RNP specifically (a sliceosome protein) are highly associated with MCTD
tRNA structure
3’ end –> CCA: carries amino acid
T arm –> binds ribosome (closest to 3’ end)
Anti-codon loop –> recognizes codon
D arm –> recognized by tRNA synthetase
Protein synthesis
- Initiation: initiated by GTP hydrolysis
- Elongation: APE site: Aminoacyl tRNA comes in, Peptide bond formed, Empty tRNA exits
- Termination: stop codon recognized (UGA, UAA, UAG)
I (Inclusion) cell disease
- lysosomal storage disorder based on defective phosphotransferase which fails to phosphorylate mannose residues (in Golgi) and proteins are secreted EC instead of delivered as glycoproteins to lysosomes
- coarse facies, clouded corneas, restricted joint movement, high levels of lysosomal enzymes in blood
- often fatal in childhood
vesicular trafficking proteins:
Clathrin
COP I
COP II
Clathrin: from Golgi to lysosomes, plasma membrane to endosomes
COP I: retrograde Golgi to Golgi or Golgi to ER
COP II: anterograde ER to Golgi or Golgi to Golgi
Peroxisome
degrades very long chain and branched chain FA as well as AAs
Proteosome
degrades the damaged or ubiquitin-tagged proteins
Drugs that act on MTs
Microtubules Get Constructed Very Poorly:
Mebendazole
Griseofulvin
Colchicine
Vincristine/Vinblastine - vincas destabilize
Paclitaxel - taxanes stabilize
Cilia structure and Kartagener Syndrome
- structure = 9+2 array (9 MT doublets around outside, 2 MTs in center)
- Axonemal dynein = ATPase that links the doublets ad causes bending by differential sliding
- Dynein arm defect = can’t move, get Kartagener or primary ciliary dyskinesia; infertility in M/F, can also cause bronchiectasis, sinusitis, and situs inversus
Inhibitors of the Na/K pump
- Ouabain - binds K+ site, inhibits
- Digoxin/Digitoxin - directly inhibits ATPase and also indirectly inhibits Na/Ca exchanger which increases cardiac contractility
Locations of each type of Cartilage
I - Bone, skin, tendons; decreased in OI type I
II - Cartilage
III - Reticulin (skin, vessels, uterus, fetus, granulation tissue); deficient in vascular Ehlers-Danlos (uncommon)
IV - Basement membranes; defective in Alport syndrome, auto-Abs in Goodpasture
“Be (So Totally) Cool, Read Books”
Collagen synthesis
All in RER of fibroblasts:
1. Synthesis: Gly-X-Y (where X/Y are proline or lysine)
2. Hydroxylation: by prolyl/lysyl hydroxylase, which require Vitamin C (scurvy)
3. Glycosylation, then make triple helix of 3 collagen alpha chains (if problem here: OI)
Exocytosis of procollagen into EC space where proteolytic processing and cross-linking happens:
4. Cleave disulfide-rich terminal regions of procollagen
5. Cross-link staggered fibers by Cu-containing lysyl oxidase (inhibited by Lathrogens, e.g. sweet peas)
Osteogensis Imperfecta
MCC: AD decreased production of otherwise normal type I collagen; manifests as brittle bones, blue sclera, dental probs (lack of dentin), and hearing issues (abnormal ossicles)
*Glycine in Gly-X-Y is replaced by a bulkier AA and the triple helix can’t be formed
Ehlers-Danlos syndrome
- Classical type - mutation in type V collagen
- Vascular type - mutation in type III collagen
- Can be AD (MCC) or AR because the defect can be in fibrous protein or enzyme genes.
- Manifestations include stretchy skin, bleeding tendency, hypermobile joints; may also see joint dislocation, berry/aortic aneurysm, organ rupture
Menkes disease
- CT disease caused by impaired Cu absorption/transport because lysyl oxidase needs Cu as a co-factor to make CT
- results in brittle hair, growth retardation, and hypotonia
Marfan Syndrom
- defect in fibrillin, a glycoprotein that forms a sheath around elastin
- makes elastin too stretchy because the fibrillin isn’t there to stabilize it